Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06810063 · ClinicalTrials.gov registry record
Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth
A clinical trial of Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Ohio State University.
- Active
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT06810063: Active study of Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Ohio State University.
NCT06810063 is a study of Cerebral Palsy and Hemiplegic Cerebral Palsy that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 35 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06810063, a study of Cerebral Palsy and Hemiplegic Cerebral Palsy, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this study: 1. Determine if a play based test of arm and hand movements is valid and reliable when conducted through telehealth for children with hemiplegic cerebral palsy. 2. Measure differences in parent, provider and child engagement when an assessment is conducted in-person compared to via telehealth. 3. Rate caregivers' overall impressions of procedures when an assessment is conducted in-person compared to telehealth. Participants will attend two visits, one in person and one through telehealth. During each visit, the child will play with common toys. The sessions will be video recorded and scored using two standardized assessments, the Melbourne Assessment-2 (MA-2) and the Assisting Hand Assessment.
Primary Outcome
Upper Extremity assessment, range 0-100, higher score indicates better outcomes.
Conditions Studied
Interventions
- OTHER Assessment only, no intervention
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2023-09-29 |
| Est. Completion | 2026-05 |
What the registry record for NCT06810063 still lists
NCT06810063 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Assessment only, no intervention is the first listed.
NCT06810063 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06810063 about?
NCT06810063 is a clinical study titled "Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth". The goals of this study: 1. Determine if a play based test of arm and hand movements is valid and reliable when conducted through telehealth for children with hemiplegic cerebral palsy. 2. Measure differences in parent, provider and child engagement when an assessment is conducted in-person compare...
What is the current status of trial NCT06810063?
This trial is currently active not recruiting. The enrollment target is 35 participants. The study started on 2023-09-29. Estimated completion is 2026-05.
What conditions does trial NCT06810063 study?
This clinical trial studies the following conditions: Cerebral Palsy, Hemiplegic Cerebral Palsy.
What interventions are being tested in trial NCT06810063?
The interventions under investigation include: Assessment only, no intervention (OTHER).
Who is sponsoring clinical trial NCT06810063?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06810063 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06810063's enrollment target sits among peer trials
35 50th of 91 higher than 40 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI